MAXIMIZING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY PROVIDERS AND RAS ASSAYS

while in the swiftly evolving field of oncology research, precise and effective mutation screening is critical for establishing focused therapies. The KRAS companies System plays a pivotal purpose During this landscape by featuring extensive methods for KRAS mutation profiling and Assessment. KRAS mutations, present in around ninety five% of RAS-co